AirPods Pro 2 have been around for three years at this point, with Apple rolling out features post-launch like a USB-C charging case and hearing aid functionality, but it wasn’t until September 2025 ...

Telitacicept, a new dual inhibitor of the cytokines B-lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand), showed efficacy in adults with active systemic lupus erythematosus (SLE) ...

Tesla unveiled more affordable versions of its best-selling Model Y SUV and its Model 3 sedan, but the starting prices of $39,990 and $36,990 struck some as too high to attract a new class of buyers ...

Oct 7 (Reuters) - Tesla (TSLA.O), opens new tab unveiled more affordable versions of its best-selling Model Y SUV and its Model 3 sedan on Tuesday at $39,990 and $36,990, respectively, as the electric ...

Tesla’s new ‘more affordable models’ have been released, and they’re stripped-down versions of the Model 3 and Model Y. They’re currently the cheapest cars in Tesla’s lineup at base price of $37k and ...

For nearly two decades, CEO Elon Musk has promised Tesla would make a more affordable electric vehicle, to, as he put it in 2006, “help expedite the move from a mine-and-burn hydrocarbon economy ...

KALAMAZOO COUNTY, Mich. — The driver of a military vehicle lost control after changing lanes Monday and set off a chain reaction resulting in an eight-vehicle crash that injured three. Previous: Crash ...

Tesla has unveiled the long-promised cheaper versions of its two main cars, dubbed the Model 3 Standard and Model Y Standard, after the expiration of the $7,500 tax credit for American buyers of most ...

The U.S. Space Force has selected SpaceX and United Launch Alliance to perform the first seven launches under the National Security Space Launch Program, or NSSL, Phase 3 Lane 2 contracts, Breaking ...

COLUMBUS, Ohio -- Ohio Republicans are pressing forward with overriding Gov. Mike DeWine’s property-tax reform vetoes less than 24 hours after his work group recommended their ideas be moderated ...

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that the Phase 3 EXCALIBER-RRMM study evaluating iberdomide, an investigational cereblon E3 ligase modulator (CELMoD™ ...

Regeneron is racing to regulators after reporting a phase 3 win in an ultrarare disease. The biotech plans to file for FDA approval of garetosmab in fibrodysplasia ossificans progressiva (FOP) by the ...